Market Tracker

11/21 2:12pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

19.95
Delayed Data
As of 1:56pm ET
 +0.45 / +2.31%
Today’s Change
13.60
Today|||52-Week Range
33.00
+6.12%
Year-to-Date

Today’s Trading

Previous close19.50
Today’s open19.65
Day’s range19.65 - 20.25
Volume508,201
Average volume (3 months)874,278
Market cap$911.6M
Dividend yield--
Data as of 1:56pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+570.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.10+0.61%
ZIOPZIOPHARM Oncology In...+0.01+0.35%
ATNXAthenex Inc+0.07+0.39%
BYSIBeyondspring Inc0.000.00%
Data as of 2:12pm ET, 11/21/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$1.00
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts